a developer of therapeutics to treat autoimmune and allergic diseases, cancer and other conditions
Industry Biotechnology
A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with RLAY. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then RLAY could also see price increases.
Ticker / NAME | Correlation To XNCR | 1D Price Change % | ||
---|---|---|---|---|
XNCR | 100% | -0.42% | ||
RLAY - XNCR | 55% Loosely correlated | -2.19% | ||
TECH - XNCR | 52% Loosely correlated | +2.04% | ||
ERAS - XNCR | 49% Loosely correlated | -4.68% | ||
BEAM - XNCR | 49% Loosely correlated | -1.57% | ||
ABCL - XNCR | 45% Loosely correlated | -1.35% | ||
More |
Ticker / NAME | Correlation To XNCR | 1D Price Change % |
---|---|---|
XNCR | 100% | -0.42% |
allergic theme (4 stocks) | 79% Closely correlated | -5.90% |
cancer theme (82 stocks) | 55% Loosely correlated | -2.38% |
drugs theme (254 stocks) | 50% Loosely correlated | -1.72% |
autoimmune theme (3 stocks) | 46% Loosely correlated | -2.17% |
therapeutics theme (53 stocks) | 44% Loosely correlated | -2.44% |
More |